-
Older men with early stage prostate cancer had survival similar to those without cancer; for two-thirds of these men, cardiovascular diseases and other cancers were more likely to cause death than prostate cancer.
-
The FDA has approved a new muscarinic receptor antagonist for the treatment of overactive bladder.
-
The lead II rhythm strip shown above was obtained from an elderly patient with shortness of breath. How wide is the QRS complex?
-
-
The JUPITER trial causes a stir; ACP practice guideline for antidepressant use; testosterone for low libido; continued shortage of Hib vaccine; FDA Actions.
-
Strong evidence was found that slow gait speed, low physical activity, and weight loss are key indicators of frailty, which is associated with chronic disability, long-term nursing home stays, injurious falls, and death.
-
The syllogistic process that led us all to accept the utility of ASA in prevention of CVD in diabetics seemed innocent enough: a) ASA reduces CV events in persons with CVD, and b) diabetes is considered a CV risk equivalent; therefore, c) ASA must reduce CV events in persons with diabetes.
-
The American College of Physicians has just published a new clinical practice guideline on the use of second-generation antidepressants in treating depressive disorders.
-
The FDA has approved a new, highly selective alpha-1 adrenergic receptor antagonist for the treatment of benign prostatic hyperplasia (BPH).
-
The relationship between uric acid (URA) and cardiovascular (CV) risk has been the subject of controversy for decades.
